{
    "summary": "This bill, the \"Producing Incentives for Long-term production of Lifesaving Supply of medicine Act\" or \"PILLS Act,\" aims to incentivize the domestic production of generic drugs and biosimilars. It establishes a tax credit for the production and sale of eligible components (including generic drugs, biosimilars, and related materials), with a higher credit percentage for certain substances and a bonus for domestic content. It also creates an investment tax credit for qualified facilities involved in producing these components, with provisions for elective payments and credit transfers. The bill includes phase-out provisions for production credits and specifies effective dates for the changes.",
    "tags": [
        "Healthcare",
        "Economic recovery",
        "Tax reform",
        "Job creation",
        "Healthcare access",
        "Opioid crisis"
    ],
    "category": "Healthcare & Public Health"
}